These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36428153)

  • 61. Pathways and Mechanism of Caffeine Binding to Human Adenosine A
    Do HN; Akhter S; Miao Y
    Front Mol Biosci; 2021; 8():673170. PubMed ID: 33987207
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Structural dynamics of Smoothened (SMO) in the ciliary membrane and its interaction with membrane lipids.
    Kumari S; Mitra A; Bulusu G
    Biochim Biophys Acta Biomembr; 2022 Aug; 1864(8):183946. PubMed ID: 35483421
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Retrospective ensemble docking of allosteric modulators in an adenosine G-protein-coupled receptor.
    Bhattarai A; Wang J; Miao Y
    Biochim Biophys Acta Gen Subj; 2020 Aug; 1864(8):129615. PubMed ID: 32298791
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Copper (Cu
    Jing J; Tu G; Yu H; Huang R; Ming X; Zhan H; Zhan F; Xue W
    Phys Chem Chem Phys; 2021 May; 23(20):11717-11726. PubMed ID: 33982037
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mutagenesis at the human tachykinin NK(2) receptor to define the binding site of a novel class of antagonists.
    Meini S; Bellucci F; Catalani C; Cucchi P; Patacchini R; Rotondaro L; Altamura M; Giuliani S; Giolitti A; Maggi CA
    Eur J Pharmacol; 2004 Mar; 488(1-3):61-9. PubMed ID: 15044036
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hydrophobic Ligand Entry and Exit Pathways of the CB1 Cannabinoid Receptor.
    Jakowiecki J; Filipek S
    J Chem Inf Model; 2016 Dec; 56(12):2457-2466. PubMed ID: 27966915
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1.
    Pandey S; Li XX; Srivastava A; Baidya M; Kumari P; Dwivedi H; Chaturvedi M; Ghosh E; Woodruff TM; Shukla AK
    J Biol Chem; 2019 Jun; 294(24):9416-9429. PubMed ID: 31036565
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Activation of corticotropin-releasing factor 1 receptor: insights from molecular dynamics simulations.
    Singh R; Ahalawat N; Murarka RK
    J Phys Chem B; 2015 Feb; 119(7):2806-17. PubMed ID: 25607803
    [TBL] [Abstract][Full Text] [Related]  

  • 69. C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.
    Zheng QY; Liang SJ; Xu F; Li GQ; Luo N; Wu S; Li Y; Tang M; Zhong Y; Chen J; Yang D; Sun DD; Zhang KQ; Xu GL
    Front Immunol; 2019; 10():1866. PubMed ID: 31447855
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In silico study of the structurally similar ORL1 receptor agonist and antagonist pairs reveal possible mechanism of receptor activation.
    Senćanski M; Dosen-Mićović L
    Protein J; 2014 Jun; 33(3):231-42. PubMed ID: 24659500
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mechanistic Insights into Peptide Binding and Deactivation of an Adhesion G Protein-Coupled Receptor.
    Adediwura VA; Miao Y
    Molecules; 2023 Dec; 29(1):. PubMed ID: 38202747
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interaction of Human C5a with the Major Peptide Fragments of C5aR1: Direct Evidence in Support of "Two-Site" Binding Paradigm.
    Das A; Behera LM; Rana S
    ACS Omega; 2021 Sep; 6(35):22876-22887. PubMed ID: 34514259
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Potential Link between the C5a Receptor 1 and the β1-Adrenoreceptor in the Mouse Heart.
    Khor KH; Moore TA; Shiels IA; Greer RM; Arumugam TV; Mills PC
    PLoS One; 2016; 11(1):e0146022. PubMed ID: 26727203
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility.
    Tan SM; Ziemann M; Thallas-Bonke V; Snelson M; Kumar V; Laskowski A; Nguyen TV; Huynh K; Clarke MV; Libianto R; Baker ST; Skene A; Power DA; MacIsaac RJ; Henstridge DC; Wetsel RA; El-Osta A; Meikle PJ; Wilson SG; Forbes JM; Cooper ME; Ekinci EI; Woodruff TM; Coughlan MT
    Diabetes; 2020 Jan; 69(1):83-98. PubMed ID: 31624141
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism.
    Dalton JA; Lans I; Giraldo J
    BMC Bioinformatics; 2015 Apr; 16(1):124. PubMed ID: 25902715
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
    Pandey P; Roy KK; Doerksen RJ
    J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Homology modeling and antagonist binding site study of the human histamine H2 receptor.
    Zhang J; Qi T; Wei J
    Med Chem; 2012 Nov; 8(6):1084-92. PubMed ID: 22779803
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of C5a-C5aR1 axis in bone pathophysiology: A mini-review.
    Ruocco A; Sirico A; Novelli R; Iannelli S; Van Breda SV; Kyburz D; Hasler P; Aramini A; Amendola PG
    Front Cell Dev Biol; 2022; 10():957800. PubMed ID: 36003145
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The mechanism of high affinity pentasaccharide binding to antithrombin, insights from Gaussian accelerated molecular dynamics simulations.
    Balogh G; Komáromi I; Bereczky Z
    J Biomol Struct Dyn; 2020 Oct; 38(16):4718-4732. PubMed ID: 31686597
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Computational modeling of cyclic peptide inhibitor-MDM2/MDMX binding through global docking and Gaussian accelerated molecular dynamics simulations.
    Wang YT; Cheng TL
    J Biomol Struct Dyn; 2021 Jul; 39(11):4005-4014. PubMed ID: 32448094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.